Optical probes and the applications in multimodality imaging

Contrast Media and Molecular Imaging

Volumn 6, Issue 4, 2011, Pages 169-177

  Liu, Yang ^a,b,c   Yu, Gang ^a,b,c   Tian, Mei ^d   Zhang, Hong ^a,b,c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Key Laboratory of Medical Molecular Imaging of Zhejiang Province   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fluorescence imaging; Fluorophore; Molecular imaging; Multimodal imaging; Optical probes; Report gene

Indexed keywords

CARBOCYANINE; CYANINE DYE; CYANINE DYE 3; CYANINE DYE 5; CYANINE DYE 5.5; CYANINE DYE 7; FLUORESCEIN; FLUORESCENT DYE; FLUOROPHORE; INDOCYANINE GREEN; LANTHANIDE; LUCIFERASE; OXAZINE DERIVATIVE; QUANTUM DOT; RHODAMINE; THYMIDINE KINASE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BIOLUMINESCENCE; DRUG TARGETING; FLUORESCENCE IMAGING; HUMAN; IN VIVO STUDY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; OPTICAL PROBE; PRIORITY JOURNAL; REPORTER GENE; REVIEW;

ANIMALS; DIAGNOSTIC IMAGING; FLUORESCENCE; HUMANS; MOLECULAR IMAGING;

EID: 80051917183     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.428     Document Type: Review

References (86)

1. Nuiachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng 2006; 8: 1-33.
2. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7(5): 626-634.
3. Ballou B, Ernst LA, Waggoner AS. Fluorescence imaging of tumors in vivo. Curr Med Chem 2005; 12(7): 795-805.
4. Rao JH, Dragulescu-Andrasi A, Yao HQ. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007; 18(1): 17-25.
5. Hilderbrand SA, Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 2010; 14(1): 71-79.
6. Licha K. Contrast Agents for Optical Imaging. Springer: Berlin, 2002; 1-29.
7. Sameiro M, Goncalves T. Fluorescent labeling of biomolecules with organic probes. Chem Rev 2009; 109(1): 190-212.
8. Ernst LA, Gupta RK, Mujumdar RB, Waggoner AS. Cyanine dye labeling reagents for sulfhydryl-groups. Cytometry 1989; 10(1): 3-10.
9. Mujumdar RB, Ernst LA, Mujumdar SR, Lewis CJ, Waggoner AS. Cyanine dye labeling reagents - sulfoindocyanine succinimidyl esters. Bioconjug Chem 1993; 4(2): 105-111.
10. Southwick PL, Ernst LA, Tauriello EW, Parker SR, Mujumdar RB, Mujumdar SR, Clever HA, Waggoner AS. Cyanine dye labeling reagents - carboxymethylindocyanine succinimidyl esters. Cytometry 1990; 11(3): 418-430.
11. Mujumdar RB, Ernst LA, Mujumdar SR, Waggoner AS. Cyanine dye labeling reagents containing isothiocyanate groups. Cytometry 1989; 10(1): 11-19.
12. Xiong CY, Lu W, Zhang R, Tian M, Tong W, Gelovani J, Li C. Cell-permeable tc-99m(co3) -labeled fluorogenic caspase 3 substrate for dual-modality detection of apoptosis. Chem Eur J 2009; 15(36): 8979-8984.
13. Hodl C, Strauss WSL, Sailer R, Seger C, Steiner R, Haslinger E, Schramm HW. A novel, high-affinity, fluorescent progesterone receptor antagonist. Synthesis and in vitro studies. Bioconjug Chem 2004; 15(2): 359-365.
14. Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M, Wiederhold KH, Gremlich HU. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 2005; 23(5): 577-583.
15. Wang SL, Kim YK, Chang YT. Diversity-oriented fluorescence library approach (dofla) to the discovery of chymotrypsin sensor. J Combin Chem 2008; 10(3): 460-465.
16. Wang SL, Chang YT. Discovery of heparin chemosensors through diversity oriented fluorescence library approach. Chem Commun 2008; 10: 1173-1175.
17. Ahn YH, Lee JS, Chang YT. Selective human serum albumin sensor from the screening of a fluorescent rosamine library. J Combin Chem 2008; 10(3): 376-380.
18. Lee JS, Kim YK, Vendrell M, Chang YT. Diversity-oriented fluorescence library approach for the discovery of sensors and probes. Mol BioSyst 2009; 5(5): 411-421.
19. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307(5709): 538-544.
20. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22(8): 969-976.
21. Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J Nucl Med 2009; 50(4): 493-496.
22. So MK, Xu CJ, Loening AM, Gambhir SS, Rao JH. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol 2006; 24(3): 339-343.
23. Rhyner MN, Smith AM, Gao XH, Mao H, Yang LL, Nie SM. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine 2006; 1(2): 209-217.
24. Zhang H, Yee D, Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine 2008; 3(1): 83-91.
25. Bunzli JC. Lanthanide luminescence for biomedical analyses and imaging. Chem Rev 2010; 110(5): 2729-2755.
26. Wang KZ, Wang K, Li WH, Huang T, Li RF, Wang D, Shen BZ, Chen XY. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol 2009; 50(10): 1095-1103.
27. Ballou B, Fisher GW, Waggoner AS, Farkas DL, Reiland JM, Jaffe R, Mujumdar RB, Mujumdar SR, Hakala TR. Tumor labeling in-vivo using cyanine-conjugated monoclonal-antibodies. Cancer Immunol Immun 1995; 41(4): 257-263.
28. Birchler M, Neri G, Tarli L, Halin C, Viti F, Neri D. Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers. J Immunol Meth 1999; 231(1-2): 239-248.
29. Ogawa M, Regino CAS, Seidel J, Green MV, Xi WZ, Williams M, Kosaka N, Choyke PL, Kobayashi H. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem 2009; 20(11): 2177-2184.
30. Citrin D, Lee AK, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K. In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol Cancer Ther 2004; 3(4): 481-488.
31. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grotzinger C. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001; 19(4): 327-331.
32. Jin ZH, Josserand V, Foillard S, Boturyn D, Dumy P, Favrot MC, Coll JL. In vivo optical imaging of integrin alpha(v)-beta(3) in mice using multivalent or monovalent crgd targeting vectors. Mol Cancer 2007; 6.
33. Cai W, Shin D-W, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006; 6(4): 669-676.
34. McCarthy JR, Patel P, Botnaru I, Haghayeghi P, Weissleder R, Jaffer FA. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug Chem 2009; 20(6): 1251-1255.
35. Bhargava S, Licha K, Knaute T, Ebert B, Becker A, Grotzinger C, Hessenius C, Wiedenmann B, Schneider-Mergener J, Volkmer-Engert R. A complete substitutional analysis of vip for better tumor imaging properties. J Mol Recognit 2002; 15(3): 145-153.
36. Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL. Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J Med Chem 2002; 45(10): 2003-2015.
37. Moon WK, Lin YH, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 2003; 14(3): 539-545.
38. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 2003; 63(8): 1936-1942.
39. McGreevy JM, Cannon MJ, Grissom CB. Minimally invasive lymphatic mapping using fluorescently labeled vitamin B-12. J Surg Res 2003; 111(1): 38-44.
40. Bhushan KR, Tanaka E, Frangioni JV. Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Edn 2007; 46(42): 7969-7971.
41. Kang JH, Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med 2008; 49: 164S-179S.
42. Blasberg RG, Gelovani-Tjuvajev J. In vivo molecular-genetic imaging. J Cell Biochem 2002; 172-183.
43. Giepmans BNG, Adams SR, Ellisman MH, Tsien RY. Review - the fluorescent toolbox for assessing protein location and function. Science 2006; 312(5771): 217-224.
44. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005; 5(10): 796-806.
45. Shu XK, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 2009; 324(5928): 804-807.
46. Lin MZ, McKeown MR, Ng HL, Aguilera TA, Shaner NC, Campbell RE, Adams SR, Gross LA, Ma W, Alber T, Tsien RY. Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chem Biol 2009; 16(11): 1169-1179.
47. Bhaumik S, Gambhir SS. Optical imaging of renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002; 99(1): 377-382.
48. Roda A, Guardigli M, Michelini E, Mirasoli M. Bioluminescence in analytical chemistry and in vivo imaging. Trac Trends in Anal Chem 2009; 28(3): 307-322.
49. Branchini BR, Ablamsky DM, Davis AL, Southworth TL, Butler B, Fan F, Jathoul AP, Pule MA. Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 2010; 396(2): 290-297.
50. Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 2004; 64(5): 1579-1583.
51. Li C, Wang W, Wu QP, Shi K, Houston J, Sevick-Muraca E, Dong L, Chow D, Charnsangavej C, Gelovani JG. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 2006; 33(3): 349-358.
52. Wang W, Ke S, Kwon S, Yallampalli S, Cameron AG, Adams KE, Mawad ME, Sevick-Muraca EM. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug Chem 2007; 18(2): 397-402.
53. Bhushan KR, Misra P, Liu F, Mathur S, Lenkinski RE, Frangioni JV. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc 2008; 130(52): 17648.
54. Cai WB, Chen K, Li ZB, Gambhir SS, Chen XY. Dual-function probe for pet and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 2007; 48(11): 1862-1870.
55. Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 2007; 48(9): 1501-1510.
56. Mulder WJM, Strijkers GJ, Habets JW, Bleeker EJW, van der Schaft DWJ, Storm G, Koning GA, Griffioen AW, Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005; 19(12): 2008.
57. Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY, Kang HW, Jon S. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 2007; 129(42): 12739-12745.
58. Bridot JL, Faure AC, Laurent S, Riviere C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Vander Elst L, Muller R, Roux S, Perriat P, Tillement O. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 2007; 129(16): 5076-5084.
59. Mishra A, Pfeuffer J, Mishra R, Engelmann J, Mishra AK, Ugurbil K, Logothetis NK. A new class of GD-based DO3A-ethylamine-derived targeted contrast agents for mr and optical imaging. Bioconjug Chem 2006; 17(3): 773-780.
60. Frullano L, Meade TJ. Multimodal MRI contrast agents. J Biol Inorg Chem 2007; 12(7): 939-949.
61. Culver J, Akers W, Achilefu S. Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med 2008; 49(2): 169-172.
62. Jennings LE, Long NJ. 'Two is better than one'-probes for dual-modality molecular imaging. Chem Commun 2009; 24: 3511-3524.
63. Lee S, Chen XY. Dual-modality probes for in vivo molecular imaging. Mol Imag 2009; 8(2): 87-100.
64. Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, Prasad PN. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010; 4(2): 699-708.
65. Kamaly N, Kalber T, Kenny G, Bell J, Jorgensen M, Miller A. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI. Org Biomol Chem 2010; 8(1): 201-211.
66. Xie J, Chen K, Huang J, Lee S, Wang JH, Gao J, Li XG, Chen XY. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 2010; 31(11): 3016-3022.
67. Stelter L, Pinkernelle JG, Michel R, Schwartlander R, Raschzok N, Morgul MH, Koch M, Denecke T, Ruf J, Baumler H, Jordan A, Hamm B, Sauer IM, Teichgraber U. Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3t MRI, small animal PET, and fluorescence imaging. Mol Imag Biol 2010; 12(1): 25-34.
68. Ke JH, Lin JJ, Carey JR, Chen JS, Chen CY, Wang LF. A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. Biomaterials 2010; 31(7): 1707-1715.
69. Xu JS, Huang JW, Qin RG, Hinkle GH, Povoski SP, Martin EW, Xu RX. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials 2010; 31(7): 1716-1722.
70. Hwang DW, Ko HY, Lee JH, Kang H, Ryu SH, Song IC, Lee DS, Kim S. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010; 51(1): 98-105.
71. Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M, Regino C, Kobayashi H, Choyke PL. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imag 2009; 8(6): 341-354.
72. Pelley JL, Daar AS, Saner MA. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 2009; 112(2): 276-296.
73. Chudakov DM, Lukyanov S, Lukyanov KA. Fluorescent proteins as a toolkit for in vivo imaging. Trends Biotechnol 2005; 23(12): 605-613.
74. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997; 66(4): 523-531.
75. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001; 358(9283): 727-729.
76. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18(3): 321-325.
77. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed 2006; 19(5): 581-592.
78. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, Ivanova A, Ageyeva L, Tourkova V, Balatoni J, Bornmann W, Blasberg R, Tjuvajev JG. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imag 2004; 31(5): 740-751.
79. Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan CW, Slack M, Sadelain M, Breakefield XO, Tjuvajev JG. Functional coexpression of hsv-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1999; 1(2): 154-161.
80. Ponomarev V, Doubrovin M, Serganova I, Beresten T, Vider J, Shavrin A, Ageyeva L, Balatoni J, Blasberg R, Tjuvajev JG. Cytoplasmically retargeted hsv1-tk/gfp reporter gene mutants for optimization of noninvasive molecular-genetic imaging. Neoplasia 2003; 5(3): 245-254.
81. Ray P, Tsien R, Gambhir SS. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 2007; 67(7): 3085-3093.
82. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 2004; 64(4): 1323-1330.
83. Ray P, Wu AM, Gambhir SS. Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 2003; 63(6): 1160-1165.
84. Ray P, De A, Patel M, Gambhir SS. Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. Clin Cancer Res 2008; 14(18): 5801-5809.
85. Waerzeggers Y, Klein M, Miletic H, Himmelreich U, Li HF, Monfared P, Herrlinger U, Hoehn M, Coenen HH, Weller M, Winkeler A, Jacobs AH. Multimodal imaging of neural progenitor cell fate in rodents. Mol Imag 2008; 7(2): 77-91.
86. Daadi MM, Li ZJ, Arac A, Grueter BA, Sofilos M, Malenka RC, Wu JC, Steinberg GK. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 2009; 17(7): 1282-1291.